Browse by Title

Type here to filter the list

U
Ulinastatin and Radiation-Induced Brain Injury via Inhibition of Notch 1 in Mice (2884)
Favorite

Ning SU ### 2372437###Presenter#########
Presenter: Ning SU
### 2884
Ultrafast Short-Arc Diffusion-Based Cone Beam CT Image Reconstruction (1097)
Favorite

Xiang Li, PhD – Memorial Sloan Kettering Cancer Center ### 2437468###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Memorial Sloan Kettering Cancer Center###
Presenter: Xiang Li, PhD – Memorial Sloan Kettering Cancer Center
### 1097
Ultra-Hypofractionated Involved Site Radiation Therapy (ISRT) as Salvage or Bridging Therapy in Aggressive Non-Hodgkin Lymphomas (1123)
Favorite

Tanooha Veeramachaneni, BS – UT Southwestern Medical School ### 2371926###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###UT Southwestern Medical School###
Presenter: Tanooha Veeramachaneni, BS – UT Southwestern Medical School
### 1123
Ultra-Hypofractionated One-Week Locoregional Radiation for Early Breast Cancer: Dose Distribution to Target Volumes and Organs-at-Risk (2722)
Favorite

Ivica Ratosa, MD, PhD – Institute of Oncology Ljubljana ### 747141###Presenter###Disclosures: Employment: Institute of Oncology Ljubljana:Radiation Oncologist:Employee | Compensation: Swixx Biopharma: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Honoraria-End Date: 22.09.2022 | Ownership: none | Leadership: none###Institute of Oncology Ljubljana###
Presenter: Ivica Ratosa, MD, PhD – Institute of Oncology Ljubljana
### 2722
Ultra-Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcoma
Favorite

Anusha Kalbasi, MD – Stanford University ### 1954274###Speaker###Disclosures: Employment: Stanford University:Associate Professor:Employee | Compensation: Certis Oncology: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: ongoing ;T Cure Therapeutics: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: ongoing ;Highlight Therapeutics: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: ongoing | Ownership: none | Leadership: none###Stanford University###
Speaker: Anusha Kalbasi, MD – Stanford University
###
Ultra-Hypofractionated Radiation in Older Patients with Low Risk Early-Stage Breast Cancer (2683)
Favorite

Bin Gui, MD, MS – Northwell Health ### 1972616###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Northwell Health###
Presenter: Bin Gui, MD, MS – Northwell Health
### 2683
Ultra-Hypofractionated Whole Breast Radiation Therapy Using a Novel Boost Regimen for Early-Stage Breast Cancer (2665)
Favorite

Molly Chakraborty, BSE – Rutgers New Jersey Medical School ### 2371896###Presenter###Disclosures: Employment: Memorial Sloan Kettering Cancer Center:Medical Student Researcher:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Rutgers New Jersey Medical School###
Presenter: Molly Chakraborty, BSE – Rutgers New Jersey Medical School
### 2665
Ultra-Low-Dose Adaptive Radiotherapy and Single-Agent Rituximab for Indolent Non-Hodgkin Lymphomas: Where Less is More in Combined Modality Therapy (3394)
Favorite

Katherine Lake, BA – UT Southwestern Medical School ### 2372729###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT Southwestern Medical School###
Presenter: Katherine Lake, BA – UT Southwestern Medical School
### 3394
Ultra-Short-Course Hormone Therapy for Intermediate Risk Prostate Cancer Treated with Definitive Radiotherapy: Retrospective Analysis of a National Healthcare System (3264)
Favorite

Alex Bryant, MD, MS – University of Michigan ### 524711###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###University of Michigan###
Presenter: Alex Bryant, MD, MS – University of Michigan
### 3264
Unbiased Functional Genomics Screen Identifies Unique Therapeutic Vulnerabilities in Osimertinib-Resistant NSCLCs (2795)
Favorite

Alex Gooding, MD, PhD – Duke University ### 2372457###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Duke University###
Presenter: Alex Gooding, MD, PhD – Duke University
### 2795
Uncertainty Estimation in Radiotherapy Dose Prediction with Deep Learning for Head and Neck Cancers (3349)
Favorite

Liting Chen ### 2372177###Presenter#########
Presenter: Liting Chen
### 3349
Uncertainty Quantification in Machine Learning Radiotherapy Applications - A Scoping Review (3385)
Favorite

Zaphanlene Kaffey, MS – UT MD Anderson Cancer Center ### 2372738###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###UT MD Anderson Cancer Center###
Presenter: Zaphanlene Kaffey, MS – UT MD Anderson Cancer Center
### 3385
Uncovering Racial Bias in AI Models and Algorithms
Favorite

Laleh Seyyed-Kalantari, PhD – York University ### 2319733###Speaker###Disclosures: Employment: York University:Assistant Professor:Employee | Compensation: CFREF: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 04/2028 ;Google: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 04/2028 ;NSERC Discovery Grant: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: 04/2028 | Ownership: none | Leadership: none###York University###
Speaker: Laleh Seyyed-Kalantari, PhD – York University
###
Understanding Current Processes of Multidisciplinary Collaboration in Radiation Oncology Treatment Planning and Follow-Up across NCORP Network Practices (3649)
Favorite

Michael Farris, MD – Wake Forest University Medical Center ### 525334###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: Wake Forest hospital:Copyright | Leadership: none###Wake Forest University Medical Center###
Presenter: Michael Farris, MD – Wake Forest University Medical Center
### 3649
Understanding Equity, Diversity and Inclusion within Canadian Radiation Oncology: Experiences of Residents and Fellows (2003)
Favorite

Jennifer Croke, MD, MHPE – Princess Margaret Cancer Centre ### 524777###Presenter###Disclosures: Employment: Princes Margaret Cancer Centre:Radiation Oncologist:Employee | Compensation: Merck: Education Meeting Faculty, Honoraria-End Date: present | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###
Presenter: Jennifer Croke, MD, MHPE – Princess Margaret Cancer Centre
### 2003
Understanding the Landscape of Radiation Therapy in Alexandria, Egypt: A Comprehensive Study on Physicians, Supporting Staff and Patients Perspectives (2107)
Favorite

Ahmed Nawwar, MD, MPH – Harvard Medical College/Brigham and Women's Hospital/Dana Farbar Cancer Institute ### 2372134###Presenter###Disclosures: Employment: Harvard T. Chan School of Public Health:MPH Student:Other | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Harvard Medical College/Brigham and Women's Hospital/Dana Farbar Cancer Institute###
Presenter: Ahmed Nawwar, MD, MPH – Harvard Medical College/Brigham and Women's Hospital/Dana Farbar Cancer Institute
### 2107
Unet-Attention Guided Cycle Generative Adversarial Networks Based Synthetic 4DCT from 4D-CBCT Generation for Lung Cancer Stereotactic Body Radiotherapy (2465)
Favorite

Xiangyu Zhang – West China Hospital of Sichuan University ### 2372317###Presenter######West China Hospital of Sichuan University###
Presenter: Xiangyu Zhang – West China Hospital of Sichuan University
### 2465
University of Groningen, Netherlands: Prospective Data Registration for NTCP-Model Development and Validation
Favorite

Johannes Langendijk, MD, PhD – University Medical Center Groningen ### 747535###Speaker###Disclosures: Employment: University Medical Center Groningen:Professor:Employee | Compensation: IBA: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Grant Research Funding, Honoraria, Travel Expenses-End Date: 2025 ;RaySearch: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Grant Research Funding-End Date: 2025 | Ownership: none | Leadership: none###University Medical Center Groningen###
Speaker: Johannes Langendijk, MD, PhD – University Medical Center Groningen
###
University of Michigan Radiation Oncology Analytics Resource (MROAR) System: 9 Years Experience with Standardizations Enabling Automated Aggregation and Analysis from Comprehensive Real-World Data
Favorite

Charles Mayo, PhD, FASTRO, FAAPM – University of Michigan ### 524947###Speaker###Disclosures: Employment: University of Michigan:Professor:Employee | Compensation: CodeX Steering Committee: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: to present ;EPIC Radiation Oncology Steering Board: Advisory Board, Advisory Board Type, Advisory Board Proprietary-End Date: to present | Ownership: Fuse Oncology Inc:Copyright | Leadership: American Association of Physicists in Medicine:Vice Chair Data Science Committee###University of Michigan###
Speaker: Charles Mayo, PhD, FASTRO, FAAPM – University of Michigan
###
Unlocking the Simulation-Omitted Spine SAbR: Advancing Efficiency with Advanced CBCT and Online Adaptive Therapy (175)
Favorite

Da Wang, PhD – UT Southwestern Medical Center ### 2371860###Presenter######UT Southwestern Medical Center###
Presenter: Da Wang, PhD – UT Southwestern Medical Center
### 175
Unplanned Hospitalizations and Lymphopenia after Proton Beam Therapy (PBT) vs. Intensity-Modulated Radiation Therapy (IMRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC): An Analysis of 74 (2061)
Favorite

Michelle Iocolano, MD, MA – University of Pennsylvania ### 538369###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Pennsylvania###
Presenter: Michelle Iocolano, MD, MA – University of Pennsylvania
### 2061
Unraveling the Mechanism behind Prophylactic Radiotherapy to Prevent Traumatic Heterotopic Ossification (131)
Favorite

Meng-Lun Hsieh, DO, PhD – University of Texas Southwestern Medical Center ### 2483548###Presenter###Disclosures: Employment: UT Southwestern Medical Center:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Texas Southwestern Medical Center###
Presenter: Meng-Lun Hsieh, DO, PhD – University of Texas Southwestern Medical Center
### 131
Unraveling the Molecular Mechanisms of Radioresistance in Breast Cancer: A Transcriptomic and Proteomic Analysis (2840)
Favorite

Reine Abou Zeidane, MD – Case Western Reserve School of Medicine ### 2371842###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Case Western Reserve School of Medicine###
Presenter: Reine Abou Zeidane, MD – Case Western Reserve School of Medicine
### 2840
Unveiling Patient and Provider Perceptions on Medical Tattoos in Breast Cancer Radiotherapy (2697)
Favorite

Grace Lee, RT, MHSc – Princess Margaret Cancer Centre ### 2371995###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Princess Margaret Cancer Centre###
Presenter: Grace Lee, RT, MHSc – Princess Margaret Cancer Centre
### 2697
Unveiling the Intricate Interplay of ROS, Autophagy and p53 in Radioresistance of Hepatocellular Carcinoma (2842)
Favorite

Yu-Wei Lin, MD, PhD, MS – Kaohsiung Veterans General Hospital ### 525372###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Kaohsiung Veterans General Hospital###
Presenter: Yu-Wei Lin, MD, PhD, MS – Kaohsiung Veterans General Hospital
### 2842
Updates from ARRO
Favorite

Emily MacDuffie, MD – University of Pennsylvania ### 800114###Speaker###Disclosures: Employment: University of Pennsylvania:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Pennsylvania###
Speaker: Emily MacDuffie, MD – University of Pennsylvania
###
Upfront Stereotactic Body Radiotherapy to the Residual Primary Lung Lesions after First-Line Systemic Therapy in Polymetastatic Non-Small Cell Lung Cancer (2152)
Favorite

Dan Tao, MD – Chongqing University Cancer Hospital ### 1972069###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Chongqing University Cancer Hospital###
Presenter: Dan Tao, MD – Chongqing University Cancer Hospital
### 2152
Uptake and Positivity Rates of PSMA PET Staging for Newly Diagnosed Prostate Cancer in a National Healthcare System (3240)
Favorite

Sean Miller, MD – University of Michigan ### 747156###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Michigan###
Presenter: Sean Miller, MD – University of Michigan
### 3240
Uptake of Attendee Pronoun Selection at Time of Registration for the 65th ASTRO Annual Meeting (2034)
Favorite

Jason Domogauer, MD, PhD – NYU Langone Laura and Isaac Perlmutter Cancer Center ### 525196###Presenter###Disclosures: Employment: New York University, School of Medicine:Attending:Employee | Compensation: Novartis: Consultant, Compensation Payment-End Date: 9/22/23 | Ownership: none | Leadership: none###NYU Langone Laura and Isaac Perlmutter Cancer Center###
Presenter: Jason Domogauer, MD, PhD – NYU Langone Laura and Isaac Perlmutter Cancer Center
### 2034
Urethra and Bladder Dosimetry in Patients Treated with Prostate SBRT with and without Intra-Prostatic Boost (IPB) (2225)
Favorite

Nisha Bhargava, BS – Beth Israel Deaconess Medical Center ### 2372271###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beth Israel Deaconess Medical Center###
Presenter: Nisha Bhargava, BS – Beth Israel Deaconess Medical Center
### 2225
Urinary Quality of Life in Patients Treated with Prostate SBRT with Intra-Prostatic Boost (2815)
Favorite

Nisha Bhargava, BS – Beth Israel Deaconess Medical Center ### 2372271###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Beth Israel Deaconess Medical Center###
Presenter: Nisha Bhargava, BS – Beth Israel Deaconess Medical Center
### 2815
Urine Cell-Free DNA Analysis to Detect Tumor Tissue of Origin and Predict Pathologic Complete Response across Genitourinary Malignancies (1104)
Favorite

Pradeep Chauhan, PhD – Mayo Clinic Rochester ### 2391414###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: Cancer biomarker Patent:Copyright | Leadership: none###Mayo Clinic Rochester###
Presenter: Pradeep Chauhan, PhD – Mayo Clinic Rochester
### 1104
Use of a Dedicated Palliative Radiation Oncology Service to Address Disparities in Access to and Expedite Receipt of Care
Favorite

Anna LaVigne, MD – Johns Hopkins University School of Medicine ### 1972276###Speaker###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Johns Hopkins University School of Medicine###
Speaker: Anna LaVigne, MD – Johns Hopkins University School of Medicine
###
Use of the 40-Gene Expression Profile (40-GEP) Test to Identify Immune Suppressed Patients with Brigham and Womens Hospital (BWH) T1-T2a Cutaneous Squamous Cell Carcinoma (cSCC) at Higher Risk of Meta (1065)
Favorite

Shlomo Koyfman, MD – Cleveland Clinic Foundation ### 535784###Presenter###Disclosures: Employment: Cleveland Clinic Foundation:Physician:Employee | Compensation: galera therapeutics: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Compensation Payment-End Date: Aug 2023 ;Merck: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Grant Research Funding, Travel Expenses, Compensation Payment-End Date: ongoing ;BMS: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Research Grants, Research Funding, Research Salary Support,Grant Research Funding, Compensation Payment-End Date: ongoing ;Regeneron: Advisory Board, Advisory Board Type, Advisory Board Proprietary, Research Grants, Research Funding, Research Salary Support,Grant Research Funding, Compensation Payment-End Date: ongoing ;castle biosciences: Consultant, Research Grants, Research Funding, Research Salary Support,Grant Research Funding-End Date: ongoing ;UpToDate: Compensation Payment-End Date: ongoing | Ownership: none | Leadership: none###Cleveland Clinic Foundation###
Presenter: Shlomo Koyfman, MD – Cleveland Clinic Foundation
### 1065
User Evaluation of Metal Artifact Reduction Reconstruction for Daily Radiotherapy Treatment Imaging (2233)
Favorite

Ashley Cetnar, PhD, MS – The Ohio State University ### 2372291###Presenter###Disclosures: Employment: The Ohio State University:Medical Physicist:Employee;University of Wisconsin-LAX:Adjunct Faculty:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: Journal of Applied Clinical Medical Physics:Board of Directors and Associate Editor###The Ohio State University###
Presenter: Ashley Cetnar, PhD, MS – The Ohio State University
### 2233
Using a Large Language Model (LLM) for Automated Extraction of Discrete Elements from Clinical Notes for Creation of Cancer Databases (3371)
Favorite

Marissa Gilbert, BS – Henry Ford Hospital ### 2372762###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Henry Ford Hospital###
Presenter: Marissa Gilbert, BS – Henry Ford Hospital
### 3371
Using High-Repeatable Radiomic Features Improves the Cross-Institutional Generalization of Prognostic Model in Esophageal Cancer Receiving Definitive Chemoradiotherapy (3373)
Favorite

Jie Gong, PhD – Life Sciences Research Center, School of Life Sciences and Technology, Xidian University, ### 2372768###Presenter######Life Sciences Research Center, School of Life Sciences and Technology, Xidian University,###
Presenter: Jie Gong, PhD – Life Sciences Research Center, School of Life Sciences and Technology, Xidian University,
### 3373
Using Large Language Models to Create Patient Centered Consent Forms (3342)
Favorite

Jacob Beattie ### 2372778###Presenter#########
Presenter: Jacob Beattie
### 3342
Using Virtual Monoenergetic Images and Electron Density (Rho) Images from Photon-Counting CT (PCCT) for Radiation Therapy (RT) Dose Calculation: A Comparison Study (1031)
Favorite

Xin Wu, MS – Duke University Medical Center ### 2371962###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Duke University Medical Center###
Presenter: Xin Wu, MS – Duke University Medical Center
### 1031
Using Virtual Reality Technology to Improve Patient Anxiety and Reduce Opioids Use during HDR Brachytherapy Procedure for Patients with Gynecological Cancer (2878)
Favorite

Santanu Samanta, MD – University of Arkansas for Medical Sciences (UAMS) ### 593749###Presenter######University of Arkansas for Medical Sciences (UAMS)###
Presenter: Santanu Samanta, MD – University of Arkansas for Medical Sciences (UAMS)
### 2878
USP15 and Radiation-Induced DNA Damage Repair of Intestinal Epithelial Cells by Deubiquitinating and Stabilizing ATM (135)
Favorite

Ruiqiu Zhu, MD, PhD – Soochow University ### 2371839###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Soochow University###
Presenter: Ruiqiu Zhu, MD, PhD – Soochow University
### 135
Utility of ⁶⁸Ga DOTA-Octreotate PET/CT in Characterization of Pediatric Neuroendocrine Tumors (3543)
Favorite

Elizabeth McKone, MD – Mayo Clinic Rochester ### 1972061###Presenter###Disclosures: Employment: Mayo Clinic Rochester:Resident Physician:Employee | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Mayo Clinic Rochester###
Presenter: Elizabeth McKone, MD – Mayo Clinic Rochester
### 3543
Utility of Analytics in a Large Community-Based Radiation Oncology Network: Consolidation and Standardization of Clinical, Operational and Quality Metrics (3386)
Favorite

Andrew Kennedy, MD, FACRO – Sarah Cannon Cancer Center at TriStar Health ### 524663###Presenter###Disclosures: Employment: none | Compensation: ABK Biomedical: Consultant, Research Grants, Research Funding, Research Salary Support,Travel Expenses, Compensation Payment-End Date: present ;Bard: Consultant, Compensation Payment-End Date: present | Ownership: none | Leadership: none###Sarah Cannon Cancer Center at TriStar Health###
Presenter: Andrew Kennedy, MD, FACRO – Sarah Cannon Cancer Center at TriStar Health
### 3386
Utility of Virtual Information Sessions to Inform Medical Students about Radiation Oncology Residency Programs (3528)
Favorite

Conley Kriegler, MD – University of Alberta ### 2371791###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###University of Alberta###
Presenter: Conley Kriegler, MD – University of Alberta
### 3528
Utilization Assessment of the Introductory Radiation Oncology Curriculum (IROC) for Radiation Oncology Trainees (3570)
Favorite

Amanda Stark, MD – VCU Health Stony Point/Massey Cancer Center ### 2372812###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###VCU Health Stony Point/Massey Cancer Center###
Presenter: Amanda Stark, MD – VCU Health Stony Point/Massey Cancer Center
### 3570
Utilization of Brain-Directed Therapy for Patients with Melanoma Brain Metastases Treated with Ipilimumab and Nivolumab (2545)
Favorite

Troy Kleber, MD, MS – MD Anderson Cancer Center ### 1972837###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###MD Anderson Cancer Center###
Presenter: Troy Kleber, MD, MS – MD Anderson Cancer Center
### 2545
Utilization of FCDenseNet for Auto-Contouring in Radiation Therapy for Companion Animals (3460)
Favorite

Ha-Yeong Yoon, MS – Oncosoft ### 2372721###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Oncosoft###
Presenter: Ha-Yeong Yoon, MS – Oncosoft
### 3460
Utilization of Inpatient Radiation Therapy and Spine Surgery during Hospitalization for Metastatic Spinal Cord Compression (2564)
Favorite

Sifan Lu, BA – Maimonides Medical Center/SUNY Downstate HSU ### 1972927###Presenter###Disclosures: Employment: none | Compensation: :Role Topic Description-End Date: | Ownership: none | Leadership: none###Maimonides Medical Center/SUNY Downstate HSU###
Presenter: Sifan Lu, BA – Maimonides Medical Center/SUNY Downstate HSU
### 2564
Utilizing Large Language Models for Enhanced Clinical Trial Matching (3341)
Favorite

Jacob Beattie ### 2372778###Presenter#########
Presenter: Jacob Beattie
### 3341
Utilizing of a Dedicated Radiation Oncology Documentation Software Designed with Physician Input and Note Completion Times (3133)
Favorite

Joshua Asper, PA-C – Mays Cancer Center, UT Health San Antonio, MD Anderson Cancer Center ### 2372664###Presenter###Disclosures: Employment: none | Compensation: none | Ownership: none | Leadership: none###Mays Cancer Center, UT Health San Antonio, MD Anderson Cancer Center###
Presenter: Joshua Asper, PA-C – Mays Cancer Center, UT Health San Antonio, MD Anderson Cancer Center
### 3133